2,156 material Form 8-K filings that 1,847 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Century Communities' board elected James Francescon, age 37, as President effective January 1, 2027, succeeding Robert J. Francescon in that role. Robert J. Francescon remains Chief Executive Officer and becomes the sole principal executive officer, while Executive Chairman Dale Francescon no longer shares that title. The filing discloses a $750,000 base salary and a promotional award of 35,008 restricted stock units for James Francescon, and it reports no financial results.
Base salary of $750,000 and a target annual bonus of at least 200% of base salary, effective January 1, 2027.
Promotional RSU award of 35,008 shares, granted November 4, 2026, vesting in three equal annual installments.
Robert J. Francescon becomes sole principal executive officer; James Francescon is his son and Dale Francescon's nephew.
Company announced the promotion in a press release dated November 9, 2026, as part of its succession planning.
Sonoco said CEO R. Howard Coker will retire as director, president and chief executive officer effective December 31, 2026. The board named Ernest D. Haynes III, the company's president of Global Consumer Packaging, to succeed him as CEO and as a director on that date.
Coker's retirement is effective December 31, 2026; the board accepted his notice dated November 6, 2026.
Haynes, who joined Sonoco in 1997, has an annual base salary of $1,100,004 and a bonus target of 120% of salary.
CFO Paul Joachimczyk received a $1,500,000 restricted stock unit retention award that cliff vests on the second anniversary of the grant date.
Sonoco leadership, including Coker, Haynes and Joachimczyk, will present at an R.W. Baird conference webcast on November 10, 2026, starting 7:20 a.m. Central Time.
LKQ Corporation said Salvatore A. Abbate will become President and Chief Executive Officer and join the Board effective November 9, 2026, earlier than the previously announced December 15, 2026 start date. The change ends the interim Office of the CEO led by Chairman John Mendel and Audit Committee Chair Sue Gove, which had overseen operations since October 23, 2026.
Abbate's start date moved from December 15, 2026 to November 9, 2026
Abbate becomes principal executive officer for SEC rules on November 9, 2026
Interim Office of the CEO, Mendel and Gove, which oversaw operations since October 23, concludes
Chairman Mendel said the Board has full confidence in Abbate
SiriusXM announced that Board director Anjali Sud, current CEO of Tubi, will become Chief Executive Officer on January 1, 2027, succeeding Jennifer C. Witz, who steps down as CEO and board member at the end of December 31, 2026. Sud's employment agreement sets a $2,600,000 base salary, a target bonus of two times salary, and equity awards including a $10,000,000 sign-on grant, which shareholders can track in the filing.
Anjali Sud, 43, becomes CEO effective January 1, 2027, and will remain on the Board
Sud's employment agreement sets a $2,600,000 base salary and a target bonus equal to two times base salary
Sud's package includes a $10,000,000 sign-on RSU grant and $4,500,000 in time-based and $4,500,000 in performance-based RSUs
Witz will serve as an advisory consultant from January 1, 2027 through December 31, 2027 at $175,000 per month
Goodyear appointed Roger Wood, a current board member, as interim chief executive officer and president effective November 8, 2026, replacing Mark Stewart, who also resigned from the board. The company will search for a permanent successor while a board special committee continues a strategic review of its businesses and operations.
Wood's salary is $310,000 per month, plus a monthly restricted stock unit grant with a grant date value of $1,000,000 for up to five months or until a permanent successor is hired.
Stewart's separation is classified as a termination other than for Cause under the company's Executive Severance and Change in Control Plan.
Wood will step down as chair of the board's human capital and compensation committee and will not serve on the Human Capital and Compensation or Governance Committees while interim CEO.
Jerome Rouquet will become executive vice president and chief financial officer effective December 1, 2026, succeeding interim CFO Scott Deakin.
Azora Therapeutics appointed three new independent directors, Aida Habtezion, Paul Hastings and Thomas Soloway, effective November 3, 2026, and four directors resigned the same day, reducing the board to five members. Separately, 9,924,260 common shares were issued on conversion of Series A Preferred Stock, bringing common shares outstanding to 14,243,129 as of November 4, 2026.
Three directors appointed November 3, 2026: Aida Habtezion, M.D., Paul Hastings and Thomas Soloway; the board was reduced to five members
Four directors resigned effective November 3, 2026: J. Kermit Anderson, Cary J. Claiborne, Robertson H. Gilliland and Kevin Schuyler; Matthew Davidson was named board chair
9,924,260 common shares issued on automatic conversion of 9,924.260 Series A Preferred shares effective November 2, 2026; 3,006.341 preferred shares remain outstanding
Company has not finalized non-employee director compensation; no equity awards granted to the new directors
Vistance Networks CEO Chuck Treadway, who has led the company since October 2020, will step down as President, CEO and board member effective February 1, 2027, after resigning on November 4, 2026. The board has launched a search for a successor and retained an executive search firm, and Treadway's severance is contingent on signing a separation agreement with a general release.
Treadway resigned November 4, 2026 and leaves the CEO role and board on February 1, 2027.
Treadway's departure is treated as a resignation for good reason under his Severance Protection Agreement, with severance contingent on a separation agreement containing a general release.
The company says it returned $16.50 per share to shareholders through special cash distributions in 2026, including a $1.50 per share distribution payable November 6, 2026.
The company released third quarter 2026 results in a separate press release issued the same day, November 5, 2026.
Datavault AI's board appointed Brett Moyer as Chief Executive Officer and President, effective immediately, after Nathaniel Bradley was removed from that role on November 1, 2026. Board changes also name Kimberly Briskey Chair and Teresa Gallo Chief Operating Officer, a shake-up that bears on how the company is run and governed.
Brett Moyer, previously CFO and a director, named CEO and President effective November 6, 2026; Nathaniel Bradley removed as CEO on November 1, 2026
Stanley Mbugua, previously Chief Accounting Officer, named Chief Financial Officer; Teresa Gallo named Chief Operating Officer
Kimberly Briskey named Chair of the Board; Christopher R. Hardt named Chair of the Audit Committee
Company says it will report third-quarter 2026 results on a date to be announced
RPM International's Chairman and CEO Frank C. Sullivan announced on November 6, 2026 that he plans to retire within the next twelve to eighteen months. He will remain in his role until a successor is appointed and is expected to then stay on as Chair of the Board, as the company runs a succession planning process with its Board.
Frank C. Sullivan plans to retire in the next twelve to eighteen months, per the November 6, 2026 filing.
Sullivan has served nearly 25 years as Chairman and CEO and more than 40 years with the company.
He will remain CEO until his successor is appointed and is expected to stay on as Board Chair afterward.
GeoVax Labs said on November 5, 2026 that its Board terminated David A. Dodd as President and Chief Executive Officer, effective immediately, and treated the termination as for Cause under his 2018 Employment Agreement. Dodd remains a director and Chairman, and the company does not intend to pay the severance he would receive without Cause, but he may dispute the determination, which could lead to severance and option-vesting costs.
Termination of President and CEO David A. Dodd effective immediately, dated November 5, 2026; he remains a director and Chairman
Board cites Dodd's refusal to comply with Board-approved directives as the basis for Cause
Company does not intend to pay severance, including a cash payment of three times base salary and target bonus, or full option vesting; Dodd may dispute and claim these
Company states the termination is unrelated to its business operations, financial results, or previously filed financial statements
Dutch Bros said Chief Legal Officer Victoria Tullett will retire in 2027 and move to a Strategic Advisor role effective January 1, 2027, ending her executive officer status. Kira Druyan, formerly Senior Vice President, Deputy General Counsel and Chief Ethics & Compliance Officer at Starbucks, will succeed her as Chief Legal Officer on or about January 1, 2027. The filing describes a planned executive transition and does not include financial results or guidance.
Victoria Tullett notified the company on November 4, 2026, of her decision to retire in 2027.
Tullett becomes Strategic Advisor effective January 1, 2027, and will no longer be an executive officer.
Kira Druyan is appointed Incoming Chief Legal Officer, reporting to CEO Christine Barone, and will assume the role on or about January 1, 2027.
Tullett is eligible for severance under the company's Amended and Restated Severance and Change in Control Plan, as described in the March 31, 2026 proxy statement.
DarioHealth Corp. said its board appointed John R. Palumbo as Chairman effective immediately, on November 3, 2026, following a recommendation from the Nominating Committee. He replaces Yoav Shaked, who remains on the board as a member. The filing does not state any financial results or reasons for the change.
Appointment made November 3, 2026, on the recommendation of the Nominating Committee
John R. Palumbo became Chairman of the Board effective immediately
Yoav Shaked steps down as Chairman but will continue to serve as a board member
Power Solutions International's Chief Financial Officer, Xun (Ken) Li, notified the board on November 3, 2026, that he will resign, effective November 27, 2026, to pursue another professional opportunity. The company said the resignation was not the result of any disagreement with the company.
Xun (Ken) Li resigns as Chief Financial Officer, also serving as principal financial and principal accounting officer
Notice to the board given November 3, 2026; resignation effective November 27, 2026
Company states the departure was not due to any disagreement
Data I/O Corporation announced that Douglas Adams, a former Source Electronics and Avnet executive, has been appointed SVP Global Services, Support and Quality. The appointment follows the October 21, 2026 acquisition of V-TEK, Inc. and A&J Programming, Inc., and is tied to the company's plan to enter Programming-as-a-Service. The filing contains no financial results, so the direct financial effect on shareholders is not quantified.
Douglas Adams appointed SVP Global Services, Support and Quality, announced November 3, 2026
Appointment follows the October 21, 2026 acquisition of V-TEK, Inc. and A&J Programming, Inc.
The company says the acquisition is anticipated to double its revenue
Company plans to enter Programming-as-a-Service (PaaS) with A&J's existing services operation
Algorhythm Holdings' CEO and Chairman Andrew Thompson resigned effective immediately, with the board stating no disagreement over operations, policies or practices. Director Gregory D. Smith was appointed to both roles on November 2, 2026, under a CEO agreement with a base salary of $375,000 rising to $480,000 on performance conditions.
Andrew Thompson resigned as CEO and Chairman, accepted by the board on October 30, 2026.
Gregory D. Smith, age 67 and a board member since September 2026, became CEO and Chairman on November 2, 2026.
Smith's agreement provides a 2,119,542-share restricted stock award, with 1,059,771 shares vesting immediately and 1,059,771 vesting on the first anniversary of the effective date.
Severance equals two times base salary plus maximum annual bonus; the filing reports 40,848,979 common shares outstanding as of November 4, 2026.
Datavault AI's board removed Nathaniel Bradley as Chief Executive Officer and President and terminated his employment, effective immediately, on November 1, 2026. The action was approved by all directors except Mr. Bradley, who voted against it, and he continues to serve as a board member. The filing does not name a successor or an interim leader, leaving the company's top executive role open as of the filing date.
Removal effective November 1, 2026, with employment terminated immediately
Board action approved by all directors other than Mr. Bradley, who voted against it
Mr. Bradley remains a board member until the next annual meeting or earlier resignation or removal
Change Agents Corporation appointed Chief Strategy Officer Luisa Ingargiola as principal executive officer on November 4, 2026, until it names a new Chief Executive Officer, with no added compensation. The company also issued a $250,000 promissory note to Harllon Holdings LLC with a $75,000 original issue discount, requiring repayment of $325,000 on January 1, 2027, and agreed to issue 150,000 shares to consultants for services.
Luisa Ingargiola, Chief Strategy Officer since June 3, 2026, was appointed principal executive officer on November 4, 2026, and will receive no additional compensation for the role.
Promissory note issued November 4, 2026 to Harllon Holdings LLC: $250,000 principal, $75,000 original issue discount, $325,000 due January 1, 2027.
The note may be prepaid on December 1, 2026 for $312,000.
150,000 shares of common stock agreed to be issued to consultants for services, under the Section 4(a)(2) registration exemption.
Lulu's Fashion Lounge Holdings said its President and Chief Information Officer, Mark Vos, will leave the company when his employment ends on December 31, 2026, at the end of the current term under his employment agreement. The company and Mr. Vos are still discussing possible post-employment consulting and transition terms, and the filing gives no financial results or replacement details.
Mark Vos's employment as President and Chief Information Officer ends December 31, 2026
Agreement to end employment was reached October 30, 2026, and he continues in his role until then
Post-employment consulting services and transition terms remain under discussion
Krispy Kreme's board approved an amendment to CEO Joshua Charlesworth's employment agreement on October 30, 2026. The change raises his annual cash target bonus from 100% to 150% of base salary, effective November 1, 2026, and increases his annual restricted stock unit grant from $1,000,000 to $2,500,000, starting with the 2027 grant. The filing does not state a financial reason for the change, but it raises the potential pay of the company's top executive.
Target annual cash bonus rises from 100% to 150% of base salary, effective November 1, 2026.
Annual restricted stock unit grant increases from $1,000,000 to $2,500,000, beginning with the 2027 annual grant.
Changes were approved by the Board of Directors on October 30, 2026 and disclosed in a filing dated November 5, 2026.
Goodyear's board elected David E. Phillips as Executive Vice President, Chief Legal Officer and Head of Enterprise Transformation, effective November 1, 2026. The filing sets his base salary at $850,000 and his annual incentive target at $850,000, and says a restricted stock unit grant with a grant date fair value of $1,250,000 is expected in February 2027.
Effective date of appointment: November 1, 2026
Base salary: $850,000; annual incentive target: $850,000
Expected RSU grant with grant date fair value of $1,250,000 in February 2027 under the 2022 Performance Plan
AIAI Holdings Corp disclosed that directors Donald M. Remy and Jeanne L. Phillips each notified the Board on October 30, 2026 of their intention to resign, effective that same day. The company states that neither resignation resulted from any dispute or disagreement with the company or the Board about its operations, policies or practices. The filing does not name replacements or other financial effects.
Donald M. Remy resigned as a director, effective October 30, 2026
Jeanne L. Phillips resigned as a director, effective October 30, 2026
Company says neither resignation involved a disagreement on operations, policies or practices
Filing was signed by CEO Todd Furniss on November 5, 2026
PNC's board appointed Alexander E. C. Overstrom, currently executive vice president and head of Retail Banking, as chief financial officer effective March 1, 2027. Robert Q. Reilly, the current CFO, will become executive vice chairman on the same date, serving as a senior executive advisor to Chairman and CEO William S. Demchak. The filing does not report financial results, so it contains no direct measure of business performance.
Alexander E. C. Overstrom, 42, joined PNC in 2014 and has led Retail Banking since July 2022.
Robert Q. Reilly has been CFO since 2013 and remains in the role until March 1, 2027.
Permanent successor for PNC Retail Banking will be named in the near future.
Blaize Holdings appointed Martin Costas as Chief Operations Officer and Chief Financial Officer, effective November 2, 2026, replacing CFO Harminder Sehmi, who is retiring and will assist with the transition through November 30, 2026. The filing discloses Costas's pay, including a $425,000 base salary and option grants, and the bonus he can earn tied to raising $10 million and $50 million in net financing proceeds, which links his incentive to capital raising.
Martin Costas appointed COO and CFO effective November 2, 2026; he reports to CEO Dinakar Munagala.
Harminder Sehmi retiring as CFO; transition expected to be completed by November 30, 2026.
Costas base salary is $425,000, with a target bonus of 50% of base salary tied to Qualified Financings: $10 million by December 31, 2026, and $50 million between January 1 and June 30, 2027.
Costas receives options on 4,787,837 time-vesting shares and 2,393,918 performance-vesting shares, the latter vesting if market capitalization is at least $500 million for 60 consecutive days.
Valion Bio, Inc. disclosed that Lisa Wolf, its President, Chief Operating Officer and Chief Financial Officer, has voluntarily resigned from all three roles, with the resignation effective December 11, 2026. The filing does not state a reason or name a successor, so shareholders will need to watch for a replacement announcement.
Lisa Wolf notified the Special Committee of the Board on October 31, 2026.
Her resignation covers the positions of President, Chief Operating Officer and Chief Financial Officer.
The resignation takes effect December 11, 2026, and had not yet taken effect as of the filing date.
Steven L. Bernstein retired as Chief Financial Officer, Treasurer and Secretary of Frequency Electronics, Inc. effective November 1, 2026, and will provide transition services under a consulting agreement with an initial term ending October 31, 2027. The filing sets out his consulting fee, post-retirement benefits and the conditions under which those benefits apply, which shareholders may want to note when assessing the company's finance leadership transition.
Retirement effective November 1, 2026; agreement signed October 31, 2026, effective November 1, 2026
Annual consulting fee of $282,505, paid monthly, plus pre-approved expense reimbursement
Initial consulting term ends October 31, 2027; equity awards continue to vest during the term
Annual lifetime benefit of $38,000 under his 2015 deferred compensation agreement if the term is completed or ended without Cause, subject to a release of claims
TransUnion's board appointed David Gilbert, currently Senior Vice President and CFO for International, as interim Chief Financial Officer effective January 1, 2027. The change follows CFO Todd Cello's previously announced resignation effective December 31, 2026, after which Cello will serve as a full-time advisor through March 1, 2027. The company says it continues to search for a permanent CFO.
David Gilbert, who joined TransUnion in 1991, becomes interim CFO effective January 1, 2027.
Gilbert receives a $15,000 monthly stipend for his interim service.
Separate retention awards include $150,000 in cash, paid 50% in June 2027 and 50% in December 2027, and restricted stock units with a $150,000 grant date value that vest on the first anniversary of the grant.
Todd Cello resigned as CFO on September 19, 2026, effective December 31, 2026.
Biodesix said the employment of Chief Commercial Officer Kieran O'Kane ends effective November 2, 2026. He is eligible for separation benefits under his existing Executive Severance and Change in Control Agreement, based on a qualifying termination.
Kieran O'Kane, Chief Commercial Officer, departs effective November 2, 2026, the agreed Separation Date.
Separation benefits are available under his existing Executive Severance and Change in Control Agreement, as described in the 2026 proxy statement filed April 9, 2026.
The filing does not state the dollar value of the separation benefits or name a replacement.
BridgeBio Oncology Therapeutics said its Chief Medical and Development Officer, Yong Ben, gave notice of his resignation on October 30, 2026, effective January 8, 2027. The filing states the departure was not due to any disagreement with the company's operations, policies or practices, and it does not name a successor.
Yong Ben gave notice of resignation as Chief Medical and Development Officer on October 30, 2026.
Resignation takes effect January 8, 2027.
The company states the resignation was not due to any disagreement over operations, policies or practices.
Devin G. Nunes notified the board of Renatus Tactical Acquisition Corp I on October 31, 2026, that he is resigning as a director and as Chairman, effective the same day. The company said the resignation was not due to any dispute or disagreement over its operations, policies or practices. The board now has three independent directors, one non-independent director and one vacant seat, and the company is searching for an independent director to fill it.
Devin G. Nunes resigned as director and Chairman of the Board, effective October 31, 2026
The company states the resignation was not due to any dispute or disagreement with the company or board
Board now has three independent directors, one non-independent director and one vacant seat
The company is currently searching for an independent director to join the board
Digital Turbine appointed Daniel Lentz as Chief Financial Officer effective November 2, 2026, replacing Joshua Kinsell, who was interim CFO and remains Chief Accounting Officer. Lentz's pay package includes a $450,000 base salary, a $100,000 signing bonus and performance- and time-based equity awards, which tie part of his compensation to future Adjusted EBITDA and relative shareholder return.
Daniel Lentz, 48, previously served as CFO of Commerce.com, Inc. from July 2023 until joining Digital Turbine.
Lentz's compensation includes a $450,000 annual base salary, a $100,000 signing bonus and a target annual bonus of up to 100% of base salary.
Lentz received long-term awards of $1,050,000 in performance stock units and $1,050,000 in time-based restricted stock units, granted November 30, 2026.
Joshua Kinsell stepped down as interim CFO effective November 2, 2026, and continues as Chief Accounting Officer.
GE HealthCare said Taha Kass-Hout notified the company on November 4, 2026 that he will resign as Chief Science and Technology Officer. His last day will be December 31, 2026. The filing gives no successor name or reason for the departure.
Taha Kass-Hout will resign as Chief Science and Technology Officer.
He notified GE HealthCare on November 4, 2026.
His last day at the company will be December 31, 2026.
Gibraltar Industries said Chief Financial Officer Joseph Lovechio will resign effective November 20, 2026, to pursue another opportunity, and that the filing states his departure was not due to any disagreement on operations, financial reporting, policies or practices. Treasurer Jeffrey Watorek will serve as Interim Chief Financial Officer while the company searches for a permanent successor. The change is a senior finance leadership transition, but the filing includes no financial results or guidance.
Joseph A. Lovechio resigns as Vice President and CFO, effective November 20, 2026
Jeffrey J. Watorek, Vice President and Treasurer, appointed Interim CFO, with $5,750 additional biweekly cash compensation
Lori Rizzo, Vice President and Corporate Controller, appointed principal accounting officer effective November 20, 2026
Company has commenced a search for its next Chief Financial Officer
Middleby said CEO Tim FitzGerald will step down as CEO and from the board effective March 31, 2027, and that Chief Commercial Officer Steve Spittle will become CEO on April 1, 2027. Spittle was named President effective November 5, 2026, and will join the board when he becomes CEO. The company said the succession follows its 2026 portfolio transformation and that it is also reporting third quarter 2026 results on the same day.
Timothy J. FitzGerald leaves the CEO role and the board effective March 31, 2027, and remains eligible for severance and pro-rated accelerated vesting of restricted stock units.
Steven P. Spittle became President effective November 5, 2026, and becomes CEO and a board member effective April 1, 2027.
Spittle's employment agreement, dated November 4, 2026, sets an annual base salary of $850,000 and eligibility for an annual bonus.
Tripadvisor said CEO Matt Goldberg will leave his roles as president, CEO and board member effective February 16, 2027, under a separation agreement signed November 4, 2026. CFO Michael Noonan will resign effective December 31, 2026 to pursue another opportunity, and Chief Strategy and Operations Officer Kristen Dalton will serve as interim CFO starting January 1, 2027. The filing says the departures are not the result of any disagreement with the company, and the board is working with an executive search firm to find successor leadership.
Goldberg's separation package includes $675,000 in base salary payments over 18 months and a $675,000 bonus-based payment, subject to a release and restrictive covenants.
Goldberg remains CEO through February 16, 2027, and Noonan remains CFO through December 31, 2026.
Kristen Dalton, Chief Strategy and Operations Officer since November 2025, becomes interim CFO on January 1, 2027.
Chair Jeremy Philips said the board is working with an executive search firm to identify candidates.
1stDibs reported third quarter 2026 net revenue of $23.1 million, up 5% year over year, and a net loss of $1.2 million, narrower than the $3.5 million loss a year earlier. The same day, the company said Chief Product and Marketing Officer Bradford Shellhammer will succeed David Rosenblatt as CEO on January 1, 2027, with Rosenblatt moving to Executive Chairperson.
Q3 2026 net revenue was $23.1 million, up 5% year over year; gross margin was 73.2%, compared with 74.3% in Q3 2025.
Q3 2026 Adjusted EBITDA was $1.0 million (4.5% margin), compared with $(0.2) million a year earlier; the company called it its fourth consecutive quarter of positive Adjusted EBITDA.
Q4 2026 guidance: net revenue $22.2 million to $23.4 million; Adjusted EBITDA margin 1% to 4%.
Shellhammer succeeds Rosenblatt as CEO on January 1, 2027; the board authorized a $5.0 million share repurchase on November 3, 2026.
Latigo Biotherapeutics reported a third-quarter 2026 net loss of $20.9 million, down from $24.8 million a year earlier, and cash of $401.2 million that the company expects will fund operations into 2029. The company also said Todd Smith became president and CEO effective November 3, 2026, replacing Nima Farzan, who also resigned from the board.
Q3 2026 net loss was $20.9 million, versus $24.8 million in Q3 2025; R&D expenses fell to $17.5 million from $22.1 million, while G&A rose to $5.4 million from $2.6 million.
Cash and cash equivalents were $401.2 million as of September 30, 2026, expected to fund current operating plans into 2029.
Todd Smith became CEO effective November 3, 2026, with a $775,000 base salary, a 70% target cash incentive, and an option award with a $20 million grant-date fair value.
Nima Farzan will remain an employee through January 1, 2027, receive his 2026 bonus at 100% of target, and then serve as a consultant through December 31, 2027.
Brady Corporation entered into a Share Exchange Agreement on November 4, 2026, in which William H. Brady III transferred all 1,769,314 of his Class B Common Stock shares to the company in exchange for an equal number of newly issued Class A Common Stock shares. As a result of the transaction, Elizabeth P. Bruno now holds 100% of the Class B Common Stock, representing all of the company's voting power and resulting in a change in control. Dr. Bruno also stepped down from independent board committees, and the company qualified as a controlled company under NYSE rules.
On November 4, 2026, William H. Brady III exchanged 1,769,314 shares of Class B Common Stock for 1,769,314 newly issued shares of Class A Common Stock.
Elizabeth P. Bruno acquired 100% control of the company's Class B Common Stock voting power, resulting in a change in control.
William H. Brady III agreed to a 24-month lock-up period on the newly issued Class A Common Stock.
Dr. Bruno stepped down from the Management Development and Compensation Committee and the Corporate Governance Committee.
Atmos Energy said Chairman Kim R. Cocklin will retire from the board and as Chairman at the 2027 Annual Meeting after reaching mandatory retirement age. The board approved combining the Chairman and Chief Executive Officer roles, so President and CEO J. Kevin Akers will become Chairman, subject to re-election as a director. Shareholders will see one executive holding both top roles, with an independent Lead Director continuing under the company's governance guidelines.
Kim R. Cocklin, Chairman since December 2020 and with the company since 2006, will not stand for re-election at the 2027 Annual Meeting.
J. Kevin Akers, President and CEO, will become Chairman of the Board at the 2027 Annual Meeting, subject to shareholder re-election.
Nancy K. Quinn, the current Lead Director, will continue in that role from the 2027 Annual Meeting, subject to her re-election.
The board approved the change on November 3, 2026; the filing says Cocklin's decision was not the result of any disagreement with the company.
Noble Corporation plc said on October 29, 2026 that it promoted Joey M. Kawaja, previously Senior Vice President of Operations since October 2022, to Executive Vice President and Chief Operating Officer, effective November 1, 2026. The filing reports an internal promotion of an operations executive and contains no financial results, guidance, or compensation terms.
Joey M. Kawaja promoted to Executive Vice President and Chief Operating Officer
Promotion announced October 29, 2026; effective November 1, 2026
Kawaja previously served as Senior Vice President of Operations since October 2022
HP's Board appointed Emma Walmsley, former CEO of GSK, as Chief Executive Officer effective January 4, 2027, succeeding interim CEO Bruce Broussard, who will become Board Chair on the same date and succeed Chip Bergh. The filing discloses her offer letter terms, including a $1,450,000 base salary, a $30,000,000 one-time inducement equity award and a $2,500,000 sign-on bonus, and the Board increases its authorized directorships from 12 to 13 to seat her. The filing contains no financial results, so the change is a leadership transition whose effect on performance is not stated.
Emma Walmsley, 57, served as GSK CEO from April 2017 until December 2025 and joins HP as CEO on January 4, 2027.
Bruce Broussard, interim CEO since February 2026, becomes Board Chair on January 4, 2027, succeeding Chip Bergh.
Offer letter sets a $1,450,000 annual base salary and a 200% target bonus, with a $30,000,000 one-time inducement equity award.
Walmsley receives a $2,500,000 sign-on bonus, subject to prorated repayment if she leaves voluntarily or is terminated for misconduct within 12 months.
Sally Diffley resigned as Chief Financial Officer of Morgan Stanley Investment Management Inc., the Delegated Sponsor of the Trust, on October 30, 2026. Swapnil Parab was appointed to succeed her effective November 4, 2026, and the filing does not describe any change to the Trust itself.
Sally Diffley resigned as CFO of the Delegated Sponsor on October 30, 2026
Swapnil Parab appointed CFO of the Delegated Sponsor effective November 4, 2026
Parab is Head of Financial Planning and Analysis at Morgan Stanley Investment Management and joined Morgan Stanley's Finance Division in 2009
Parab previously served as Head of Valuation Control for Fixed Income and for the Wealth and Investment Management segments
Borealis Foods notified Nasdaq on November 4, 2026 that its audit committee had only two members from September 28 to October 29, 2026, below the three-member minimum, and says it regained compliance after the Board appointed Danat Shiderkulov on October 29. The filing also discloses that lender Saule Algaziyeva, mother of director Zaure Algaziyeva, became the lender under the company's credit agreement and holder of a convertible note on July 31, 2026, leading the Board to find Zaure Algaziyeva no longer independent.
Nasdaq was notified on November 4, 2026 of an audit committee shortfall under Listing Rule 5605(c)(2)(A) from September 28 to October 29, 2026.
Danat Shiderkulov was appointed a director on October 29, 2026 and joined the audit, compensation and nominating committees.
Saule Algaziyeva took over the lender role for a $17,000,000 term loan and a $3,000,000 convertible note effective July 31, 2026.
Conversion of the convertible note into common shares remains subject to shareholder approval under Nasdaq rules.
Fastly said its President, Go to Market, Scott Lovett, plans to retire during 2027, and the company has begun searching for a Chief Revenue Officer. Under a separation agreement dated October 30, 2026, he will stay in his role through a transition period and then serve as a non-employee Senior Advisor through June 30, 2027, unless extended.
Retirement date to be determined during 2027; Lovett keeps his $450,000 base salary and $450,000 target annual commission until then
Lovett receives no new equity awards during the transition period but continues vesting existing awards through the consulting period
Consulting period runs through June 30, 2027, with a possible extension by written agreement
Fastly is conducting a search for a new Chief Revenue Officer; CEO Kip Compton will lead the search with Lovett
MNTN reported third quarter 2026 revenue of $80.3 million, up 15% year over year, and net income of $7.7 million, up 19%. The board also named director Tony Weisman as President and CEO effective November 2, 2026, replacing Mark Douglas, who will leave the company on December 3, 2026. The company updated its full year 2026 guidance, which calls for fourth quarter revenue of $75 million to $78 million, below the third quarter level.
Q3 2026 revenue was $80.3 million, up 15% year over year; net income was $7.7 million, or $0.10 per diluted share, versus $6.4 million in Q3 2025
Full year 2026 revenue is expected at $311 million to $314 million, and Adjusted EBITDA at $66 million to $68 million
Q4 2026 revenue is expected at $75 million to $78 million and Adjusted EBITDA at $8 million to $10 million
CFO Patrick Pohlen cited unforeseen execution problems in the go-to-market organization and said the sales organization is being realigned
Ensysce Biosciences said director Will Chang intends to resign after the next annual meeting, and CEO Dr. Lynn Kirkpatrick will step down as CEO and take the title of Chief Operating Officer right after that meeting. President James Morrisson is set to become CEO at the same time, a change the company had previously reported, which gives shareholders a planned leadership transition.
Annual meeting scheduled for December 14, 2026; Kirkpatrick's title change and Chang's resignation take effect around it, and both would be delayed if the meeting is delayed.
James Morrisson, the company's President, will assume the title of Chief Executive Officer immediately after the annual meeting.
Kirkpatrick agreed to amend her September 14, 2021 employment offer letter so that taking the COO role will not trigger severance obligations.
Kirkpatrick has been CEO since January 2009 and also serves as CEO of EBIR, Inc., in which the company owns 79.2%.
Processa Pharmaceuticals appointed Gregory J. Flesher as Chief Operating Officer, effective November 4, 2026, under an employment letter with a $700,000 annual base salary. The filing also discloses compensation for non-employee executive chair Dr. Sheila Gujrathi, and both executives' planned option grants depend on stockholder approval of the 2027 Equity Incentive Plan.
Flesher: $700,000 annual base salary and a discretionary target bonus of up to 60% of base salary beginning in fiscal 2027.
Planned option grant to Flesher equal to 3.0% of fully-diluted outstanding capital stock, contingent on stockholder approval of the 2027 Equity Incentive Plan at the Conversion Special Meeting.
Dr. Sheila Gujrathi, non-employee executive chair: $300,000 annual base compensation and a planned option grant equal to 1.5% of fully-diluted outstanding capital stock.
A November 4, 2026 press release announced Flesher's appointment and other leadership appointments.
Children's Place said its President and Interim Chief Executive Officer, Muhammad Asif Seemab, and Chief Strategy Officer, Muhammad Umair, resigned effective November 1, 2026, and that CFO John Szczepanski became acting President and principal executive officer under the bylaws. Board member Kim Roy and Executive Chairman Turki Saleh A. AlRajhi also stepped down, and the filing says none of the resignations involved disagreement over operations, policies, or practices. The filing does not describe a permanent successor or any change in financial results, so the effect on shareholders is unclear.
Seemab resigned as President and Interim CEO and Umair as Chief Strategy Officer, both effective November 1, 2026; both will remain on the Board
CFO John Szczepanski is acting President and principal executive officer effective November 1, 2026, with no new compensation arrangements
Kim Roy resigned from the Board effective immediately, notice dated October 30, 2026
Turki Saleh A. AlRajhi resigned as Executive Chairman on November 3, 2026, and remains Chairman of the Board
Siebert Financial Corp.'s Board of Directors appointed Richard S. Gebbia and David J. Gebbia as Co-Chief Executive Officers effective November 4, 2026. John J. Gebbia, the current CEO, steps away from the CEO position on that date and will continue as Chairman of the Board, so the leadership change is significant for shareholders.
Richard S. Gebbia and David J. Gebbia, both age 59, appointed Co-CEOs effective November 4, 2026
John J. Gebbia steps away from the CEO position on November 4, 2026 and remains Chairman of the Board
Richard S. Gebbia previously served as CEO of StockCross Financial Services, Inc. from 2007 to 2020; David J. Gebbia is President of Park Wilshire Companies, Inc. and Gebbia Holdings, LLC
The filing states the Gebbia sons are related to John J. Gebbia and that no arrangements exist under which they were selected as executive officers
Z Squared Inc. elected Jeffery Harris, its Chief Technology Officer, as a director effective November 3, 2026, filling the seat left vacant by Michelle Burke's May 22, 2026 resignation. Harris is an employee and executive officer, so he is not independent, but three of the five directors remain independent, keeping a majority under Nasdaq rules. He receives no additional director compensation.
Jeffery Harris, age 40, elected director effective November 3, 2026, filling the vacancy left by Michelle Burke's resignation
Board remains at five directors; three (Adam Sohn, Bryan Fuerst, Kenneth Cooper) are independent
Harris is not named to any board committee and receives no additional director compensation
Filing notes ongoing commercial relationships with Paradox Infrastructure LLC and Paradox Energy LLC, in which Harris holds membership interests
Picard Medical's board appointed Richard Fang, Ph.D., as permanent, full-time Chief Executive Officer effective October 28, 2026; he had served as interim CEO since June 18, 2026 and remains Chairman. The filing also discloses related-person loans from a Fang-affiliated entity, and the company had not received the $1.0 million of external funding that would have kept the earliest of those loans from coming due, so they are now payable on terms yet to be determined.
Richard Fang, Ph.D., appointed permanent CEO effective October 28, 2026; salary remains $0.4 million with no new compensation arrangement
Fang-affiliated fund lent $0.5 million at 0% interest under five loans from July 29 to October 16, 2026; no principal repaid as of October 29, 2026
As of October 29, 2026, no external funding of at least $1.0 million received; earliest loans now due on payment terms to be determined
Separate $0.7 million loan from Fang Family Fund I, LLC at 6% interest, due February 28, 2027
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.